Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Sep;33(3):244-50.
doi: 10.1055/s-0036-1586148.

Benign Prostatic Hyperplasia: Review of Modern Minimally Invasive Surgical Treatments

Tony Nimeh  1 , Brenden Magnan  1 , Y Zaki Almallah  1
Affiliations
Review

Benign Prostatic Hyperplasia: Review of Modern Minimally Invasive Surgical Treatments

Tony Nimeh et al. Semin Intervent Radiol. 2016 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interests Z.A. is/was an advisor for the UK National Institute for Health and Clinical Excellence (NICE) and the National Institute for Health Research (NIHR)—Health Technology Assessment (HTA) Program and user/trainer of various male anti-incontinence devices manufactured by American Medical Systems.

Figures

Fig. 1
Fig. 1
Medical and surgical management of benign prostatic hyperplasia (BPH) according to symptom severity and complications.
Fig. 2
Fig. 2
Urolift device illustration (Image courtesy of NeoTract, Inc.)
See this image and copyright information in PMC

References

    1. Negri E, Pelucchi C, Talamini R. et al.Family history of cancer and the risk of prostate cancer and benign prostatic hyperplasia. Int J Cancer. 2005;114(4):648–652. - PubMed
    1. Kristal A R, Schenk J M, Song Y. et al.Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol. 2008;168(12):1416–1424. - PMC - PubMed
    1. Crispo A, Talamini R, Gallus S. et al.Alcohol and the risk of prostate cancer and benign prostatic hyperplasia. Urology. 2004;64(4):717–722. - PubMed
    1. St Sauver J L Jacobson D J McGree M E Girman C J Lieber M M Jacobsen S J Longitudinal association between prostatitis and development of benign prostatic hyperplasia Urology 2008713475–479., discussion 479 - PMC - PubMed
    1. St Sauver J L, Jacobson D J, McGree M E, Lieber M M, Jacobsen S J. Protective association between nonsteroidal antiinflammatory drug use and measures of benign prostatic hyperplasia. Am J Epidemiol. 2006;164(8):760–768. - PubMed